MNKD MannKind Corporation - Common Stock
$3,90
Prix · Aoû 18, 2026
Données fondamentales au Aoû 5, 2026
Fourchette 52 semaines
$2–$7
39% of range
Note des analystes
BUY
14 analysts
Objectif de cours
$8
+105% upside
P/E (TTM)
194.8
ROE
-11.1%
Marge nette
1.7%
À propos de MannKind Corporation - Common Stock Présentation de l'entreprise depuis Wikipedia
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Lire la suite
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
MNKD Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.90
Capitalisation Boursière
$1.20B
P/E (TTM)
194.8
BPA (TTM)
$0.02
Revenus (TTM)
$349M
Rendement div.
—
ROE
-11.1%
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $7
MNKD Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$349M
2016-12-31
→
2025-12-31
BPA
$0.02
2016-12-31
→
2025-12-31
Flux de trésorerie libre
$14M
2018-12-31
→
2025-12-31
Marges
1.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
MNKD
Médiane des pairs
P/E (TTM)
194.8
—
P/S (TTM)
3.4
10.7
P/B
-23.5
5.2
Price / FCF (Cours / FCF)
87.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
MNKD
Médiane des pairs
Operating Margin (Marge d'exploitation)
11.1%
—
Net Profit Margin (Marge nette)
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
MNKD
Médiane des pairs
Current Ratio (Ratio de liquidité)
1.7
9.5
Quick Ratio (Ratio de liquidité réduite)
1.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
MNKD
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
22.2%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
51.8%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
39.9%
—
EPS YoY (BPA Année/Année)
-80.0%
—
Net Income YoY (Bénéfice net YoY)
-78.8%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
MNKD
Médiane des pairs
MNKD Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
14 analystes
- Achat fort 4 28,6%
- Achat 8 57,1%
- Conserver 2 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-08-17
Médiane
$7.50
← En dessous de tous les objectifs
$3.90
Bas
$4.75
Haut
$13.00
Objectif médian
$7.50
+92,6%
Objectif moyen
$7.97
+104,6%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.03%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 mars 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 décembre 2025 | $-0.05 | $0.01 | -0.06% |
| 30 septembre 2025 | $0.07 | $0.02 | 0.05% |
| 30 juin 2025 | $0.00 | $0.05 | -0.05% |
| 31 mars 2025 | $0.04 | $0.04 | -0.00% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Flux de trésorerie 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Taux de croissance 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Flux de trésorerie 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Valorisation (TTM) 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $349M | $286M | $199M | $100M | $75M |
| Marge d'exploitation % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Résultat net | $6M | $28M | $-12M | $-87M | $-81M |
| BPA dilué | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Ratio de liquidité réduite | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $14M | $33M | $-8M | $-88M | $-73M |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright et Wells Fargo relèvent les objectifs de cours de MannKind (MNKD)
- MannKind Corporation (MNKD) est-elle l'une des penny stocks populaires sur Robinhood à acheter ?
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 271 déclarants · $560.6M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 55 (+12 vs T. préc.) | 37 (-11 vs T. préc.) | 93 (+10 vs T. préc.) | 61 (-8 vs T. préc.) | +24.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Rubric Capital Management LP | $76 680 000 | 18 000 000 | 13,68% | Actions |
| STATE STREET CORP | $68 901 423 | 16 174 043 | 12,29% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $56 101 610 | 13 169 392 | 10,01% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $29 027 881 | 6 812 460 | 5,18% | Actions |
| Frazier Life Sciences Management, L.P. | $28 116 000 | 6 600 000 | 5,01% | Actions |
| Deep Track Capital, LP | $25 560 000 | 6 000 000 | 4,56% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $23 099 232 | 5 422 355 | 4,12% | Actions |
| 180 WEALTH ADVISORS, LLC | $21 126 835 | 4 959 351 | 3,77% | Actions |
| FMR LLC | $17 455 563 | 4 097 550 | 3,11% | Actions |
| TSP Capital Management Group, LLC | $16 923 596 | 3 972 675 | 3,02% | Actions |
| BRAIDWELL LP | $14 732 908 | 3 458 429 | 2,63% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 789 240 | 3 002 169 | 2,28% | Actions |
| VANGUARD GROUP INC | $11 888 249 | 2 096 693 | 2,12% | Actions |
| TWO SIGMA INVESTMENTS, LP | $11 475 213 | 2 693 712 | 2,05% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 070 577 | 2 598 727 | 1,97% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $9 358 279 | 2 196 779 | 1,67% | Actions |
| BANK OF AMERICA CORP /DE/ | $8 689 749 | 2 039 847 | 1,55% | Actions |
| GOLDMAN SACHS GROUP INC | $6 332 618 | 1 486 530 | 1,13% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 030 221 | 1 180 803 | 0,90% | Actions |
| BlackRock, Inc. | $4 766 748 | 1 118 955 | 0,85% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $4 486 321 | 1 053 127 | 0,80% | Actions |
| Caption Management, LLC | $4 260 000 | 1 000 000 | 0,76% | Option de vente |
| J. Goldman & Co LP | $3 478 669 | 816 589 | 0,62% | Actions |
| WELLS FARGO & COMPANY/MN | $3 473 987 | 815 490 | 0,62% | Actions |
| SCOPIA CAPITAL MANAGEMENT LP | $2 960 534 | 694 961 | 0,53% | Actions |
| Balyasny Asset Management L.P. | $2 914 296 | 684 107 | 0,52% | Actions |
| TWO SIGMA ADVISERS, LP | $2 897 166 | 510 964 | 0,52% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $2 771 407 | 650 565 | 0,49% | Actions |
| Swiss National Bank | $2 502 324 | 587 400 | 0,45% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $2 177 052 | 511 045 | 0,39% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 106 540 | 494 493 | 0,38% | Actions |
| 1492 Capital Management LLC | $2 052 136 | 481 722 | 0,37% | Actions |
| Mariner, LLC | $2 020 189 | 474 236 | 0,36% | Actions |
| MILLENNIUM MANAGEMENT LLC | $1 836 597 | 431 126 | 0,33% | Actions |
| Schonfeld Strategic Advisors LLC | $1 774 216 | 416 483 | 0,32% | Actions |
| Squarepoint Ops LLC | $1 759 644 | 413 062 | 0,31% | Actions |
| Jefferies Financial Group Inc. | $1 694 202 | 397 700 | 0,30% | Actions |
| ExodusPoint Capital Management, LP | $1 666 261 | 391 141 | 0,30% | Actions |
| JANE STREET GROUP, LLC | $1 658 418 | 389 300 | 0,30% | Option d'achat |
| Man Group plc | $1 624 023 | 381 226 | 0,29% | Actions |
| RHUMBLINE ADVISERS | $1 604 647 | 376 681 | 0,29% | Actions |
| IEQ CAPITAL, LLC | $1 544 607 | 362 584 | 0,28% | Actions |
| CITIGROUP INC | $1 499 243 | 351 935 | 0,27% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 423 692 | 334 200 | 0,25% | Option de vente |
| Bank of New York Mellon Corp | $1 422 222 | 333 855 | 0,25% | Actions |
| Caption Management, LLC | $1 414 231 | 331 979 | 0,25% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1 359 221 | 319 066 | 0,24% | Actions |
| ALPS ADVISORS INC | $1 330 615 | 312 351 | 0,24% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 216 230 | 285 500 | 0,22% | Option d'achat |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 029 075 | 241 567 | 0,18% | Actions |
| BARCLAYS PLC | $1 029 062 | 241 564 | 0,18% | Actions |
| Rafferty Asset Management, LLC | $1 008 640 | 236 770 | 0,18% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $1 002 715 | 235 379 | 0,18% | Actions |
| Aaron Wealth Advisors LLC | $1 000 878 | 234 948 | 0,18% | Actions |
| HSBC HOLDINGS PLC | $998 560 | 230 881 | 0,18% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930 294 | 379 712 | 0,17% | Actions |
| CITADEL ADVISORS LLC | $928 680 | 218 000 | 0,17% | Option d'achat |
| CITADEL ADVISORS LLC | $898 860 | 211 000 | 0,16% | Option de vente |
| Bruce & Co., Inc. | $831 011 | 195 073 | 0,15% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $775 060 | 181 939 | 0,14% | Actions |
| MetLife Investment Management, LLC | $766 442 | 179 916 | 0,14% | Actions |
| FRANKLIN RESOURCES INC | $755 021 | 177 235 | 0,13% | Actions |
| Stonepine Capital Management, LLC | $750 000 | 250 000 | 0,13% | Option d'achat |
| UBS Group AG | $715 978 | 168 070 | 0,13% | Actions |
| ALLIANCEBERNSTEIN L.P. | $693 375 | 283 010 | 0,12% | Actions |
| MORGAN STANLEY | $651 282 | 152 883 | 0,12% | Actions |
| TUDOR INVESTMENT CORP ET AL | $640 657 | 150 389 | 0,11% | Actions |
| RAYMOND JAMES FINANCIAL INC | $632 009 | 148 359 | 0,11% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613 437 | 171 372 | 0,11% | Actions |
| Jain Global LLC | $604 673 | 141 942 | 0,11% | Actions |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590 457 | 138 605 | 0,11% | Actions |
| Susquehanna Portfolio Strategies, LLC | $574 538 | 134 868 | 0,10% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570 354 | 133 886 | 0,10% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $557 723 | 130 921 | 0,10% | Actions |
| PROFUND ADVISORS LLC | $517 726 | 121 532 | 0,09% | Actions |
| Invesco Ltd. | $512 389 | 120 279 | 0,09% | Actions |
| Vanguard Global Advisers, LLC | $509 833 | 119 679 | 0,09% | Actions |
| KLP KAPITALFORVALTNING AS | $491 604 | 115 400 | 0,09% | Actions |
| Gotham Asset Management, LLC | $452 463 | 106 212 | 0,08% | Actions |
| State of New Jersey Common Pension Fund D | $403 171 | 94 641 | 0,07% | Actions |
| State of Wyoming | $403 149 | 94 636 | 0,07% | Actions |
| Police & Firemen's Retirement System of New Jersey | $386 834 | 90 806 | 0,07% | Actions |
| Amundi | $374 310 | 87 866 | 0,07% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373 478 | 87 671 | 0,07% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $359 966 | 84 499 | 0,06% | Actions |
| ARIZONA STATE RETIREMENT SYSTEM | $344 050 | 80 763 | 0,06% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338 155 | 79 379 | 0,06% | Actions |
| Aquatic Capital Management LLC | $335 300 | 78 709 | 0,06% | Actions |
| Rockefeller Capital Management L.P. | $332 996 | 78 168 | 0,06% | Actions |
| Vanguard Investments Australia, Ltd. | $314 929 | 73 927 | 0,06% | Actions |
| JANUS HENDERSON GROUP PLC | $313 658 | 127 763 | 0,06% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312 203 | 73 287 | 0,06% | Actions |
| Sequoia Financial Advisors, LLC | $296 935 | 69 703 | 0,05% | Actions |
| INTECH INVESTMENT MANAGEMENT LLC | $284 653 | 66 820 | 0,05% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $280 421 | 65 827 | 0,05% | Actions |
| China Universal Asset Management Co., Ltd. | $262 714 | 61 670 | 0,05% | Actions |
| LPL Financial LLC | $260 060 | 61 047 | 0,05% | Actions |
| SIMPLEX TRADING, LLC | $258 790 | 60 749 | 0,05% | Actions |
| Cetera Investment Advisers | $241 546 | 56 701 | 0,04% | Actions |
| Painted Porch Advisors LLC | $227 620 | 53 432 | 0,04% | Actions |
Initiés de la société 43 initiés · 27 dirigeants · 18 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 juillet 2026 M | 2 433 779 | 1 | 4 | $-990 292 |
| Hakan Edstrom | President & CEO | 27 août 2015 A | 1 114 340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 juillet 2026 F | 318 668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 août 2015 A | 106 539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 juillet 2026 F | 343 398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 juillet 2026 M | 478 966 | 0 | 1 | $-94 448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 juillet 2026 M | 1 058 142 | 0 | 2 | $-548 528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 juillet 2026 M | 797 554 | 0 | 3 | $-930 755 |
| Ajay Ahuja | Chief Medical Officer | 23 mars 2026 A | 318 200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 juillet 2025 F | 349 841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 juillet 2025 F | 460 791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 août 2022 F | 745 233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 février 2022 A | 576 690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 août 2020 A | 167 119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 juillet 2020 P | 41 059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 février 2020 A | 83 972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 juillet 2019 P | 29 584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 mai 2019 A | 43 012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 août 2017 S | 2 924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 février 2016 A | 92 200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 août 2015 F | 1 005 990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 février 2015 F | 50 624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 mars 2012 F | 133 611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 novembre 2008 F | 204 401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 août 2008 A | 14 650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 décembre 2006 A | 14 800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 août 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Administrateur | 20 mai 2026 A | 265 600 | 0 | 0 | $0 |
| Jennifer Grancio | Administrateur | 20 mai 2026 A | 244 815 | 0 | 0 | $0 |
| James Samuel Shannon | Administrateur | 20 mai 2026 A | 64 635 | 0 | 0 | $0 |
| Michael A Friedman | Administrateur | 20 mai 2026 A | 47 500 | 0 | 0 | $0 |
| Anthony C Hooper | Administrateur | 20 mai 2026 A | 236 153 | 0 | 0 | $0 |
| Christine Mundkur | Administrateur | 20 mai 2026 A | 254 493 | 0 | 0 | $0 |
| Ronald J Consiglio | Administrateur | 20 mai 2026 A | 132 342 | 0 | 0 | $0 |
| Kent Kresa | Administrateur | 15 mai 2024 A | 274 541 | 0 | 0 | $0 |
| Henry L Nordhoff | Administrateur | 14 mai 2019 A | 103 426 | 0 | 0 | $0 |
| David Maccallum | Administrateur | 16 mai 2018 A | 114 790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Administrateur | 28 août 2017 F | 81 961 | 0 | 0 | $0 |
| Abraham E Cohen | Administrateur | 17 août 2012 S | 56 424 | 0 | 0 | $0 |
| Heather Hay Murren | Administrateur | 13 août 2008 A | 10 100 | 0 | 0 | $0 |
| Kathleen Connell | Administrateur | 25 mai 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Administrateur | 25 mai 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 7 août 2026 S | 785 867 | 0 | 3 | $-427 369 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 dépôts | 10 juillet 2012 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 31 janvier 2006 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 41 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,43% | 773 251 NS | 30 avril 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,74% | 317 578 NS | 31 mai 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 29 662 SH | 8 août 2026 | Quotidien |
| AGNG · Global X Funds | 0,46% | 98 947 NS | 31 mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,34% | 625 921 NS | 30 avril 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 64 525 NS | 31 mai 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 2 170 137 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 16 814 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 330 117 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,07% | 2 772 931 SH | 8 août 2026 | Quotidien |
| ESML · iShares Trust | 0,06% | 449 515 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,06% | 11 389 NS | 31 mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 114 273 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1 771 496 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,04% | 7 830 029 SH | 8 août 2026 | Quotidien |
| ISCG · iShares Trust | 0,04% | 94 032 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,03% | 14 400 NS | 31 mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 132 607 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1 466 402 NS | 31 mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 61 465 NS | 31 mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 874 372 SH | 8 août 2026 | Quotidien |
| ISCB · iShares Trust | 0,02% | 13 557 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,02% | 11 261 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 135 688 NS | 30 avril 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 638 128 NS | 30 avril 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 11 390 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3 543 398 SH | 8 août 2026 | Quotidien |
| WSML · iShares Trust | 0,01% | 16 464 SH | 8 août 2026 | Quotidien |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12 000 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 286 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 452 118 NS | 30 avril 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 27 701 NS | 30 avril 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 1 330 NS | 31 mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 465 445 SH | 8 août 2026 | Quotidien |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 196 006 NS | 31 mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 83 220 SH | 8 août 2026 | Quotidien |
| TILT · FlexShares Trust | 0,00% | 10 345 NS | 30 avril 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 32 093 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 14 557 NS | 30 avril 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9 327 332 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26 184 SH | 8 août 2026 | Quotidien |